View in EDS

Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
Authors: Adès L; Hôpital Avicenne, Université Paris, Paris, France., Boehrer S, Prebet T, Beyne-Rauzy O, Legros L, Ravoet C, Dreyfus F, Stamatoullas A, Chaury MP, Delaunay J, Laurent G, Vey N, Burcheri S, Mbida RM, Hoarau N, Gardin C, Fenaux P
Source: Blood [Blood] 2009 Apr 23; Vol. 113 (17), pp. 3947-52. Date of Electronic Publication: 2008 Nov 05.
Publication Type: Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 18987358
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Adès+L%22">Adès L</searchLink>; Hôpital Avicenne, Université Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boehrer+S%22">Boehrer S</searchLink><br /><searchLink fieldCode="AU" term="%22Prebet+T%22">Prebet T</searchLink><br /><searchLink fieldCode="AU" term="%22Beyne-Rauzy+O%22">Beyne-Rauzy O</searchLink><br /><searchLink fieldCode="AU" term="%22Legros+L%22">Legros L</searchLink><br /><searchLink fieldCode="AU" term="%22Ravoet+C%22">Ravoet C</searchLink><br /><searchLink fieldCode="AU" term="%22Dreyfus+F%22">Dreyfus F</searchLink><br /><searchLink fieldCode="AU" term="%22Stamatoullas+A%22">Stamatoullas A</searchLink><br /><searchLink fieldCode="AU" term="%22Chaury+MP%22">Chaury MP</searchLink><br /><searchLink fieldCode="AU" term="%22Delaunay+J%22">Delaunay J</searchLink><br /><searchLink fieldCode="AU" term="%22Laurent+G%22">Laurent G</searchLink><br /><searchLink fieldCode="AU" term="%22Vey+N%22">Vey N</searchLink><br /><searchLink fieldCode="AU" term="%22Burcheri+S%22">Burcheri S</searchLink><br /><searchLink fieldCode="AU" term="%22Mbida+RM%22">Mbida RM</searchLink><br /><searchLink fieldCode="AU" term="%22Hoarau+N%22">Hoarau N</searchLink><br /><searchLink fieldCode="AU" term="%22Gardin+C%22">Gardin C</searchLink><br /><searchLink fieldCode="AU" term="%22Fenaux+P%22">Fenaux P</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2009 Apr 23; Vol. 113 (17), pp. 3947-52. <i>Date of Electronic Publication: </i>2008 Nov 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18987358
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood-2008-08-175778
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3947
    Titles:
      – TitleFull: Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Adès L
      – PersonEntity:
          Name:
            NameFull: Boehrer S
      – PersonEntity:
          Name:
            NameFull: Prebet T
      – PersonEntity:
          Name:
            NameFull: Beyne-Rauzy O
      – PersonEntity:
          Name:
            NameFull: Legros L
      – PersonEntity:
          Name:
            NameFull: Ravoet C
      – PersonEntity:
          Name:
            NameFull: Dreyfus F
      – PersonEntity:
          Name:
            NameFull: Stamatoullas A
      – PersonEntity:
          Name:
            NameFull: Chaury MP
      – PersonEntity:
          Name:
            NameFull: Delaunay J
      – PersonEntity:
          Name:
            NameFull: Laurent G
      – PersonEntity:
          Name:
            NameFull: Vey N
      – PersonEntity:
          Name:
            NameFull: Burcheri S
      – PersonEntity:
          Name:
            NameFull: Mbida RM
      – PersonEntity:
          Name:
            NameFull: Hoarau N
      – PersonEntity:
          Name:
            NameFull: Gardin C
      – PersonEntity:
          Name:
            NameFull: Fenaux P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 04
              Text: 2009 Apr 23
              Type: published
              Y: 2009
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 113
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1